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Abstract
Background:  Genomic maps of transcription factor binding sites and histone modification
patterns provide unique insight into the nature of gene regulatory networks and chromatin
structure. These systematic studies use microarrays to analyze the composition of DNA isolated
by chromatin immunoprecipitation. To obtain quantities sufficient for microarray analysis, the
isolated DNA must be amplified. Current protocols use PCR-based approaches to amplify in
exponential fashion. However, exponential amplification protocols are highly susceptible to bias.
Linear amplification strategies minimize amplification bias and have had a profound impact on
mRNA expression analysis. These protocols have yet to be applied to the analysis of genomic DNA
due to the lack of a suitable tag such as the polyA tail.
Results: We have developed a novel linear amplification protocol for genomic DNA. Terminal
transferase is used to add polyT tails to the ends of DNA fragments. Tail length uniformity is
ensured by including a limiting concentration of the terminating nucleotide ddCTP. Second strand
synthesis using a T7-polyA primer adapter yields double stranded templates suitable for in vitro
transcription (IVT). Using this approach, we are able to amplify as little as 2.5 ng of genomic DNA,
while retaining the size distribution of the starting material. In contrast, we find that PCR
amplification is biased towards species of greater size. Furthermore, extensive microarray-based
analyses reveal that our linear amplification protocol preserves dynamic range and species
representation more effectively than a commonly used PCR-based approach.
Conclusion: We present a T7-based linear amplification protocol for genomic DNA. Validation
studies and comparisons with existing methods suggest that incorporation of this protocol will
reduce amplification bias in genome mapping experiments.
Background
Systematic, microarray-based studies are rapidly advanc-
ing the fields of biology and medicine. Most commonly,
mRNA expression levels are measured on a global, often
genome-wide scale. Studies employing this approach
have contributed to our understanding of diverse biologi-
cal processes from yeast physiology [1,2] to human cancer
[3]. More recently, microarray-based approaches have
been used to characterize physical properties of the ge-
nome, for example, by mapping transcription factor bind-
ing sites [4,5] and histone modifications [6,7].
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Microarray-based genome mapping protocols utilize the
technique of chromatin immunoprecipitation (ChIP) to
isolate genomic DNA associated in vivo with a transcrip-
tion factor of interest, or with histones exhibiting a partic-
ular post-translational modification. In ChIP, whole cells
are treated with formaldehyde to covalently link DNA and
associated proteins, and the resulting mix is fragmented
by sonication. Protein-DNA complexes are then isolated
using antibodies specific for a protein of interest (e.g., a
transcription factor or a histone exhibiting a particular
covalent modification). Finally, cross-links are reversed
and protein degraded to yield purified DNA. Microarrays
have proven particularly valuable for the unbiased analy-
sis and identification of DNA isolated by ChIP.
Microarray-based mapping poses unique technical chal-
lenges. For example, ChIP typically yields only sub-micro-
gram quantities of DNA. Hence, an amplification step is
required to generate sufficient quantities of nucleic acid
for microarray analysis. This contrasts with typical mRNA
expression analyses where microgram quantities of mRNA
are available for direct analysis. Furthermore, genomic
DNA lacks a universal sequence tag for priming amplifica-
tion and labeling steps. Again, this contrasts with expres-
sion analysis where the mRNA 3' polyA tail provides a
useful priming sequence for cDNA synthesis.
These obstacles have been overcome by two related proto-
cols, both of which are based on the polymerase chain re-
action (PCR). The first protocol uses a ligation-mediated
PCR strategy (LM-PCR) in which ChIP DNA is ligated to
short DNA linkers, and then PCR amplified using the link-
er sequence for priming [4]. The second uses a random
amplification strategy (R-PCR) in which template DNA is
first copied using a specialized primer with degenerate 3'
sequence and known 5' sequence, and then PCR ampli-
fied using the known 5' sequence for priming [5,8,9]. In
both cases, the PCR steps yield quantities of nucleic acid
sufficient for microarray analysis. Labeled product can be
generated by incorporating fluorescent (or otherwise
modified) nucleotides during PCR. LM-PCR has been
used in several studies, including a systematic genome-
wide location analysis of yeast transcriptional activators
[10], and an unbiased search for E2F binding sites in a
subset of human promoters [11]. Studies employing the
R-PCR approach include genome-wide analyses of silenc-
ing enzymes [12] and histone modifications [6,7] in yeast,
and a mapping of GATA-1 binding sites within the human
β-globin locus [13].
There are, however, limitations of a PCR-based approach.
Due to the exponential kinetics of PCR amplification, se-
quence-dependent and length-dependent biases may be
amplified exponentially. Furthermore, theoretical consid-
erations suggest that amplification of low abundance spe-
cies can be highly variable. Alternative amplification
approaches have been developed for microarray-based
mRNA analyses. A widely used protocol, developed by
Eberwine and colleagues, uses T7-based linear amplifica-
tion [14]. In this procedure, double stranded cDNAs are
synthesized from mRNA by reverse-transcription (prim-
ing off the 3' polyA tail) and second strand synthesis. T7
promoters are incorporated during the cDNA synthesis,
and T7 RNA polymerase is subsequently used to tran-
scribe multiple RNA copies from each cDNA (this process
is termed in vitro transcription or 'IVT'). Recent studies
have applied this approach to microarray analysis and
found that it faithfully preserves the initial representation
of RNA species [15–17]. Other reports suggest that PCR-
based amplification may also preserve this representation
[18]. However, IVT remains more attractive from a theo-
retical perspective as biases should be less severe due to
the linear nature of the amplification [19].
To improve the accuracy of microarray-based genome
mapping protocols, we have developed a linear amplifica-
tion protocol for genomic DNA. This protocol uses a ter-
minal transferase tailing step and second strand synthesis
to incorporate T7 promoters at the ends of the DNA frag-
ments prior to IVT. We find that this approach efficiently
amplifies as little as 2.5 ng of genomic DNA. Here, the
protocol is presented along with a systematic evaluation
of its efficacy and fidelity.
Results
T7-based amplification of genomic DNA
The T7-based IVT protocol for linear amplification of ge-
nomic DNA is shown in Figure 1. Since ChIP DNA is frag-
mented randomly and lacks a universal sequence for
priming, we optimized a terminal transferase step to add
polyT tails to the 3' ends of each DNA strand. We are able
to generate tails with a tight distribution around an opti-
mal length of 30 bps by including a low concentration of
a terminating dideoxycytidine nucleotide (data not
shown). An anchored primer adapter was designed that
contains a 5' T7 promoter and a 3' polyA (18 bps in
length) stretch terminating in a single C, G, or T base. This
adapter is annealed to the genomic DNA fragments, and
Klenow is added for second strand synthesis. In addition
to extending the primer adapter, the 3'-5' exonuclease ac-
tivity of Klenow should trim 3' polyTs in excess of the 18
bps complementary to the adapter, and allow fill in of the
appropriate complementary bases (Fig 1). For each dsD-
NA species present in the starting material, these reactions
generate two dsDNAs with T7 promoters at opposite ends.
The reaction products are used as template for IVT using
the Eberwine method [14]. From a starting material of
ChIP DNA from ~2 × 108 yeast cells this protocol yields
between 30 and 60 µg RNA. This yield compares favorablyBMC Genomics 2003, 4 http://www.biomedcentral.com/1471-2164/4/19
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Figure 1
Linear amplification scheme for genomic DNA. Step 1: Double stranded DNA starting material (shown with one strand 
in black and one strand in blue) is tailed on the 3' end of each strand to generate a 20–40 bp polyT tail with a terminal dideox-
ycytidine base. Step 2a: A T7-(A)18B anchored primer adaptor is annealed to the polyT tail of each template strand. Step 2b: 
During second strand synthesis Klenow fragment of DNA Polymerase I removes the excess bases from the tail overhang via its 
3'-5' exonuclease activity, and extends from the primer to produce the second strand. This results in two double stranded 
DNAs identical to the original template, except that each has a T7 promoter at a different end. Step 3: The product of second 
strand synthesis is used as template in an in vitro transcription reaction. Step 4: To generate DNA probes for microarray anal-
ysis, amplified RNA is reverse transcribed.
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with R-PCR which yields up to 15 µg DNA from equiva-
lent starting material. To more precisely evaluate the effi-
ciency and fidelity of the linear amplification protocol, we
generated a large pool of starting material by restricting
yeast genomic DNA with Alu I (cuts AGCT, leaving blunt
ends) and gel-purifying fragments within a size range of
100–700 bps. We subjected 50 ng of the Alu I digest to
amplification by IVT and by R-PCR. The IVT yielded al-
most 80 µg RNA, while the R-PCR yielded 12 µg DNA (Ta-
ble 2). We compared the Alu I digest with the amplified
products by gel-electrophoresis (Fig 2). The IVT product
retains essentially the same size distribution as the starting
material. In contrast, the R-PCR product appears to under-
represent lower molecular weight species.
Limiting primer input improves yield
While analyzing the size distribution of the IVT product
we noted a low molecular weight species that roughly cor-
responds in size to the primer adapter. IVT protocols are
reportedly sensitive to excess starting concentrations of
the T7 primer. Baugh and colleagues were able to improve
yields when amplifying mRNA by decreasing the concen-
tration of T7 primer [16]. When we limited the mass of T7
primer adapter to approximately five times that of the
starting material with a lower limit of 50 ng (by decreasing
the second strand synthesis reaction volume), this low
molecular weight species disappeared, without decreasing
overall yields (data not shown). In this way, we were able
to efficiently amplify just 2.5 ng from the Alu I digest with
a yield of 10.3 µg (Table 2).
Evaluation of linear amplification by hybridization
We went on to evaluate the fidelity of the linear amplifi-
cation protocol by microarray analysis. Restriction by Rsa
I (cuts GTAC, leaving blunt ends) and gel-purification
were used to generate a second population of DNA. Since
Alu I and Rsa I cut at different sites, the resulting digests
contain different distributions of DNA species. 50 ng of
each pool were amplified by IVT. DNA probes, generated
by reverse transcribing the amplified RNA, were fluores-
cently labeled (Cy5 for Alu I, Cy3 for Rsa I), pooled, and
hybridized to microarrays containing the yeast open read-
ing frames. After hybridization, the microarrays were
washed and scanned, and Cy5/Cy3 ratios calculated. We
also hybridized Alu I and Rsa I probes generated by R-PCR
from 50 ng starting material, as well as probes generated
by direct labeling of 1 µg starting material.
First, we assessed the reproducibility of the IVT protocol.
Three Alu I / Rsa I datasets were independently generated
using the IVT protocol. Each dataset contains 4,481 ratios
that each reflect the relative abundance of DNA corre-
sponding to a specific array feature (yeast ORF) in the two
digests. We found the IVT protocol to be highly reproduc-
ible: correlation coefficients calculated between the
Figure 2
Size distributions for starting material and IVT 
amplified product. Lanes 1–3 each contain 250 ng DNA 
run on a 2% non-denaturing agarose gel. Lanes 4–5 each con-
tain 500 ng RNA run on a 2% denaturing agarose gel. The 
denaturing gel is necessary to eliminate RNA secondary 
structure. Lane 1: 100 bp ladder (NEB). Lane 2: starting 
material (yeast genomic DNA digested with Alu I and previ-
ously gel-purified to a size range of 100–700 bp). Lane 3: 
amplified product generated by R-PCR from 50 ng starting 
material. Lane 4: amplified RNA product generated by IVT 
from 50 ng starting material. Lane 5: 100 bp RNA Ladder 
(Ambion). The R-PCR amplified product appears to signifi-
cantly under-represent low molecular weight species. The 
IVT amplified product may slightly under-represent high 
molecular weight species. For clarity, the denaturing gel 
image was rescaled to match the ladder of the non-denatur-
ing gel.BMC Genomics 2003, 4 http://www.biomedcentral.com/1471-2164/4/19
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replicate datasets averaged 0.98. This reproducibility is
maintained even when only 5 ng starting material are
used (correlation of 0.97). The direct labeling and R-PCR
protocols are also highly reproducible, with mean correla-
tions of 0.93 and 0.91, respectively (Fig 3A).
Next, we assessed the fidelity of amplification by compar-
ing the IVT and R-PCR datasets with the direct labeling da-
taset. We assumed the direct labeling dataset to most
accurately represent the true distribution of species in the
Alu I and Rsa I digests, since no amplification was re-
quired to obtain these data. The three datasets collected
for each protocol were averaged and correlation coeffi-
cients calculated between the resulting composite data-
sets. The correlation between the IVT dataset and the
direct labeling dataset is 0.96 (Fig 3A). This value increas-
es to 0.98 when features with ratios close to 1 are excluded
from the calculation. The correlation between the R-PCR
dataset and the direct labeling dataset is 0.68 (Fig 3A). It
rises to 0.80 when features with ratios close to 1 are ex-
cluded. Correspondingly, the highest ranking features in
the direct labeling dataset overlap extensively with the
highest ranking features in the IVT dataset and, to a lesser
extent, with the highest ranking features in the R-PCR da-
taset (Fig 3B).
The high correlation between the IVT and direct labeling
datasets is evident in the scatter plot shown in Fig 4. An
analogous plot portrays the lower correlation between the
R-PCR and direct labeling datasets. These plots also illus-
trate another difference between the amplification
protocols: an examination of best fit lines calculated for
each of the plots suggests that dynamic range is increased
by IVT amplification (slope > 1), but decreased by R-PCR
amplification (slope < 1). To quantify dynamic range, we
determined the ratio values for data points two standard
deviations above and below the mean, and calculated the
range between these values by dividing the high ratio by
the low ratio. For the direct labeling dataset, the high and
low ratios are 3.1 and 0.31, respectively, for a range of 9.8.
The range for the IVT dataset is 17.4, while that for the R-
PCR dataset is 5.8 (Table 2).
Hierarchical clustering, shown in Fig 5, was used as an ad-
ditional means to identify differences between the ampli-
fication protocols [20]. Replicates for a given method
cluster closely, confirming the high reproducibility ob-
served for each method. Consistent with the correlation
analysis, the individual replicates for the IVT and direct la-
beling protocol cluster together, while the R-PCR repli-
cates cluster in a separate arm of the dendrogram. Most of
the 4,481 features shown in the cluster diagram exhibit
consistent coloring across the diagram, indicating that the
direction of enrichment is consistent for all replicates.
However, the cluster diagram highlights two groups of
genes (purple stripes) whose ratios in the R-PCR dataset
are inconsistent with their ratios in the direct labeling and
IVT datasets.
Discussion
We have developed a T7-based linear amplification proto-
col for the amplification of genomic DNA. The protocol
was specifically designed to amplify DNA isolated by
ChIP, for use in genome mapping protocols. However, it
may be useful for other studies that require amplification
of small quantities of DNA in a sequence independent
manner (e.g., DNA array comparative genomic hybridiza-
tion [21]). Although T7-based approaches for amplifica-
tion of mRNA have been described [14–17], these rely on
the 3' polyA tails for priming and incorporation of the T7
promoter. Fragmented genomic DNA, such as that gener-
ated by ChIP, does not contain such a universal sequence.
Our protocol overcomes this obstacle by adding 3' polyT
tails to the ends of the DNA fragments for use in priming
much like mRNA polyA tails. Efficient tailing by terminal
transferase requires the template DNA to be free of 3'
phosphate groups, and is highly dependent on whether
this template contains blunt- or overhanging-ends. For
DNA fragments generated by ChIP (or blunt-end restric-
tion) these limitations are effectively overcome by prior
Table 1: Mass yields generated by IVT from varying amounts of restricted DNA.
Input (ng) Yield (ug) n-fold amp*
50.0 78.7 1574
25.0 69.8 2790
10.0 54.2 5420
5.0 25.8 5163
2.5 10.3 4114
50.0 PCR 15 300
*Yield and fold amplification may be overestimated for low starting concentration due to non-specific or template independent products (see text). 
The yield for the PCR amplification could be improved by introducing more cycles. However, this would likely increase bias.BMC Genomics 2003, 4 http://www.biomedcentral.com/1471-2164/4/19
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phosphatase treatment, by using recombinant terminal
transferase enzyme, and by spiking a small quantity of ter-
minating nucleotide into the tailing reaction.
We compared our IVT protocol to a commonly used PCR
protocol that uses a partially degenerate primer to amplify
genomic DNA in a sequence independent manner (R-
PCR). Initial analyses reveal specific advantages of the IVT
approach. First, yields from IVT are significantly higher
than those obtained using R-PCR (Table 1), with a fold-
amplification similar to that obtained in mRNA linear
amplification protocols [16,17]. Since 2 µg of amplified
RNA are sufficient to generate probe for a microarray ex-
periment, RNA from a single IVT amplification can be
used for several analyses. A second advantage is that the
IVT protocol maintains the size distribution of the starting
material more effectively than R-PCR (Fig 2).
Figure 3
Comparisons of microarray data collected using direct labeling, IVT or R-PCR methods. (A) Bar graph showing 
correlations between replicates collected using the same protocol, and between the averaged datasets determined using differ-
ent protocols. (B) Venn diagrams showing overlap between sets of features with the highest Cy5/Cy3 ratios.
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To more precisely characterize amplification bias we de-
veloped a test system involving the microarray-based
analysis of two distinct populations of genomic DNA.
These populations were generated by cutting genomic
DNA from yeast with a different restriction enzyme and
size-purifying the resulting digest. The resulting pools, an
Alu I digest and a Rsa I digest, contain microgram quanti-
ties of genomic DNA, sufficient for several amplification
trials. Importantly, these quantities are also sufficient for
direct microarray analysis by direct labeling (this is not
the case for the small quantities of DNA isolated by ChIP).
Although this 'direct' analysis does require a single round
of synthesis to incorporate dye labels, no amplification is
involved. Hence, we used direct labeling as a 'gold stand-
ard' to validate the IVT and R-PCR methods.
We carried out a series of hybridization experiments using
the different protocols to compare the Alu I and Rsa I di-
gests. All three protocols were highly reproducible in our
hands. However, we found the direct labeling data to be
significantly more concordant with the IVT data than with
the R-PCR data. This higher concordance is evident as
higher correlations between the datasets, and greater over-
lap among high ranking features (Fig 4). Consistent with
these findings, when the datasets are subjected to hierar-
chical clustering, the direct labeling and IVT datasets co-
segregate (Fig 5). This clustering analysis also reveals dis-
crete subsets of features whose ratios in the R-PCR dataset
are inconsistent with their ratios in the direct labeling and
IVT datasets. In addition to portraying species representa-
tion accurately, the IVT dataset displays a significantly ex-
panded dynamic range. Taken together, these
observations suggest that IVT has considerable advantages
over R-PCR.
However, our finding that IVT is more faithful than R-PCR
comes with its own caveats, and does not necessarily im-
ply that R-PCR is an unreliable approach. First of all, it
should be noted that the restriction digest analysis is an
imperfect surrogate for ChIP experiments: the random
fragmentation of DNA in ChIP, and the systematic cutting
in the restriction analyses, each place different constraints
on an amplification method. Many of the discordant ra-
tios in the R-PCR dataset likely result from a combination
of the non-random fragmentation in the Alu I / Rsa I ex-
periment and the ineffectiveness of R-PCR in amplifying
Figure 4
Scatter plots of hybridization ratios. IVT ratios (A) or R-PCR ratios (B) are plotted against direct labeling (unamplified) 
ratios. The tight distribution of points along the fitted line in (A) illustrates the high fidelity of the IVT amplification.
-3
-2
-1
0
1
2
3
-3 -2 -1 0 1 23
Direct ratios (log2)
R
-
P
C
R
r
a
t
i
o
s
(
l
o
g
2
)
-4
-3
-2
-1
0
1
2
3
4
-4 -3 -2 -1 0 1234
Direct ratios (log2)
I
V
T
r
a
t
i
o
s
(
l
o
g
2
)BMC Genomics 2003, 4 http://www.biomedcentral.com/1471-2164/4/19
Page 8 of 11
(page number not for citation purposes)
Figure 5
Hierarchical clustering of replicate datasets generated by direct labeling, IVT and R-PCR. Each thin bar repre-
sents a single datapoint. Red bars correspond to enrichment in the Cy5-labeled Alu I probe, while green bars correspond to 
enrichment in the Cy3-labeled Rsa I probe. The dendrograms (top) indicate clustering relationships among the sample repli-
cates. The lengths of the branches represent the degree of similarity between the samples (shorter indicates higher similarity). 
Purple stripes to the right of the diagram highlight discordant areas (log ratios with opposite signs) in the R-PCR replicates rel-
ative to the direct labeling and IVT samples.
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low molecular weight species. When these discordant
genes are removed, the correlation between the R-PCR
and direct labeling datasets increases to 0.77. If the analy-
sis is further limited to features with ratios reflective of a
1.5-fold or greater intensity difference the correlation is
0.88 (compare with correlation of 0.98 for IVT versus
direct). Most mapping experiments are primarily interest-
ed in these enriched or depleted features. Our initial expe-
riences analyzing ChIP DNA by IVT suggest that results
obtained using either amplification method are compati-
ble, with overall correlations around 0.80 (C.L.L., S.L.S.,
B.E.B., unpublished). These analyses suggest that IVT and
R-PCR are both valid approaches for microarray-based ge-
nome mapping. However, we expect that the greatly in-
creased dynamic range and improved fidelity obtained
through IVT will facilitate the identification of additional
biological trends within these data.
Conclusion
In conclusion, we have presented a novel linear amplifica-
tion protocol for genomic DNA. We find that this proto-
col generates higher yields and better maintains the size
distribution of the starting material than an alternative R-
PCR approach. Extensive microarray-based analyses
suggest that improvements in yield, dynamic range and fi-
delity render linear amplification a better option for ge-
nome mapping studies.
Methods
Preparation of genomic DNA from yeast
Genomic DNA used in amplification protocols was ob-
tained either by ChIP or by restriction digests. ChIP DNA
was fragmented by sonication and isolated using antibody
against di-methyl-H3 K4 as described previously [6]. Re-
stricted genomic DNA was prepared as follows: yeast ge-
nomic DNA isolated by bead lysis, phenol/chloroform
extraction, and ethanol precipitation, was restricted either
with Alu I or with Rsa I (New England BioLabs (NEB)).
Digested products underwent electrophoresis on a 2%
agarose gel. Restriction fragments in the 100–700 bp size
range were excised from the gel and purified using the
QIAquick Gel Extraction Kit (Qiagen).
CIP treatment
Calf intestinal alkaline phosphatase (CIP) (NEB) was
used to remove 3' phosphate groups from DNA samples
prior to IVT. Up to 500 ng DNA were incubated with 2.5
U enzyme in a 10 µL volume with the supplied buffer at
37°C for 1 hour. The reaction was cleaned up with the
MinElute Reaction Cleanup Kit (Qiagen) per manufactur-
er instructions except that the elution volume was in-
creased to 20 µL.
Poly-dT tailing with terminal transferase
PolyT tails were generated using terminal transferase
(TdT) as follows. Up to 50 ng of CIP-treated template
DNA were incubated for 20 minutes at 37°C in a 10 µL so-
lution containing 20 U TdT (NEB), 0.2 M potassium ca-
codylate, 25 mM Tris-HCl pH 6.6, 0.25 mg/ml BSA, 0.75
mM CoCl2, 4.6 µM dTTP and 0.4 µM ddCTP. The reaction
was halted by the addition of 2 µL of 0.5 M EDTA pH 8.0,
and product isolated with the MinElute Reaction Cleanup
Kit (Qiagen), increasing the elution volume to 20 µL.
Second strand synthesis and incorporation of T7 promoter
Second strand synthesis and incorporation of the T7 pro-
moter sequence was carried out as follows: the 20 µL tail-
ing reaction product was mixed with 0.6 µL of 25 µM T7-
A18B primer (5'-GCATTAGCGGCCGCGAAATTAATAC-
GACTCACTATAGGGAG(A)18 [B], where B refers to C, G
or T), 5 µL 10X EcoPol buffer (100 mM Tris-HCl pH 7.5,
50 mM MgCl2, 75 mM dTT), 2 µL 5.0 mM dNTPs, and
20.4 µL nuclease-free water. In experiments with 10–50
ng starting material, the end primer concentration was
kept at 300 nM, while the reaction volume was scaled
down to maintain an end concentration of 1 ng/ul starting
material. For starting amounts less than 10 ng, the volume
was kept at 10 µL. If necessary, volume reduction of the el-
uate from the TdT tailing was performed in a vacuum cen-
trifuge on medium heat. Samples were incubated at 94°C
for 2 minutes to denature, ramped down at -1 C°/sec to
35°C, held at 35°C for 2 minutes to anneal, ramped
down at -0.5 C°/sec to 25°C and held while Klenow en-
zyme was added (NEB) to an end concentration of 0.2 U/
µL. The sample was then incubated at 37°C for 90 min-
utes for extension. The reaction was halted by addition of
Table 2: Dynamic range for direct labeling, R-PCR and IVT datasets. Relative dynamic range was determined by dividing the ratio value 
2-standard deviations above the mean by the ratio value 2-standard deviations below the mean. Dynamic range is compressed by R-
PCR. In contrast, the IVT protocol actually increases dynamic range, relative to direct labeling.
Direct-labeled R-PCR IVT
2 Stdev Low 0.31 0.41 0.23
2 Stdev High 3.1 2.4 4.1
2 Stdev Range 9.8 5.7 17.4BMC Genomics 2003, 4 http://www.biomedcentral.com/1471-2164/4/19
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5 µL 0.5 M EDTA pH 8.0 and product isolated with the
MinElute Reaction Cleanup Kit (Qiagen), increasing the
elution volume to 20 µL.
In vitro transcription
Prior to in vitro transcription, samples were concentrated
in a vacuum centrifuge at medium heat to 8 µL volume.
The in vitro transcription was performed with the T7
Megascript Kit (Ambion) per manufacturer's instructions,
except that the 37°C incubation was increased to 16
hours. The samples were purified with the RNeasy Mini
Kit (Qiagen) per manufacturer's RNA cleanup protocol,
except with an additional 500 µL wash with buffer RPE.
RNA was quantified by absorbance at 260 nm, and
visualized on a denaturing 1.25X MOPS-EDTA-Sodium
Acetate gel.
Reverse transcription and labeling
For each sample to be analyzed by microarray, 4 µg ampli-
fied RNA were primed with 5 µg random hexamers and 5
µg oligo dT and reverse-transcribed, incorporating aa-
dUTP, as described at http://www.microarrays.org. Note:
the presence/absence of the oligo dT primer does not af-
fect the RT and labeling efficiency. RT was halted with 10
µL 0.5 M EDTA, and RNA hydrolyzed by the addition of
10 µL 1 N NaOH and incubation at 65°C for 15 minutes.
Reaction cleanup and labeling with monofunctional reac-
tive Cy5 (Alu I digest) or Cy3 (Rsa I digest) dye was carried
out as described in [22] and at http://www.microar-
rays.org.
R-PCR
R-PCR samples were generated from 50 ng restricted DNA
using the Round A/ Round B protocol described in [9,12].
Briefly, Sequenase (Amersham) was used for two cycles of
synthesis using a degenerate primer (5'-GTTTCCCAGT-
CACGATCNNNNNNNNN-3' ('round A'). The resulting
end-tagged DNAs were subjected to 30 cycles of PCR using
the following primer: 5'-GTTTCCCAGTCACGATC-3'.
Amino-allyl dUTP was incorporated during the PCR step
as described in [22], and at http://www.microarrays.org.
Amplified DNA was purified with a QIAquick PCR purifi-
cation kit (Qiagen). For microarray analysis, 7 µg of each
probe were fluorescently labeled by incubation with
monofunctional reactive Cy5 (Alu I digest) or Cy3 (Rsa I
digest) dye as described [22].
Direct labeling
Unamplified DNA samples for labeling were generated
from 1 µg restricted DNA using Klenow fragment and ran-
dom primers, and incorporating amino-allyl dUTP, as de-
scribed at http://www.microarrays.org.
Microarrays, hybridization, and scanning
Yeast ORFs were amplified from a set of 6,218 plasmids
using universal primers as described [1]. This set of ORFs
was printed on separate slides, hydrated, and snap-dried
as described [1]. Mixed Cy5/Cy3-labeled probes were hy-
bridized to microarrays for 12–15 h at 60°C. After hybrid-
ization, microarrays were washed as described [1] and
scanned with a GenePix 4000B scanner with GENEPIX
PRO 4.0 software (Axon Instruments). Microarray data are
available at http://www.schreiber.chem.harvard.edu
Microarray data processing
The Cy5/Cy3 ratio for each array element was calculated
using GENEPIX PRO 4.0, log2 transformed, and normal-
ized using the default computed normalization method
used by the Stanford Microarray Database [23]. We ap-
plied a high stringency data selection, keeping only micro-
array elements for which at least 80% of the
measurements within a set of experiments had fluores-
cence intensity in both channels at least 3-fold over back-
ground intensity. 4,481 array elements passed these
selection criteria.
Comparison of amplification methods
IVT, R-PCR, and direct labeling procedures and hybridiza-
tions were each carried out in triplicate. To assess repro-
ducibility of each method, the correlation coefficients
were calculated for all possible combinations of pairs
within each set of replicates, and then averaged. Next, a
single averaged dataset was generated for each method by
determining the geometric mean for each array element
from a given set of replicates. To assess the degree of sim-
ilarity among the different methods, correlation coeffi-
cients were calculated in pair-wise comparisons of these
averaged datasets. An additional correlation coefficient
was calculated between averaged datasets using only those
features whose ratios in the direct labeling dataset reflect
at least a 1.5-fold change, either up or down.
Hierarchical clustering of the non-averaged replicate data-
sets was carried out using the Cluster program, with aver-
age linkage using Pearson correlation as the similarity
metric [20]. Clusters were visualized using TreeView [20].
To assess the degree of overlap among the different meth-
ods, the number of features among the top 500 log2 Cy5/
Cy3 ratios was determined for each pair-wise comparison
and plotted in Venn Diagrams, with the overlap region
scaled to the number of features. To assess the dynamic
range characteristics of the three methods, the range of the
data for each method was taken as an interval extending 2
standard deviations on either side of the mean across the
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